Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells.
Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells.
复制标题
重新定位到前端的抑制素可以控制结直肠癌细胞的迁移方向。
DOI:
10.18632/oncotarget.19394
复制
发表时间:
2017-09-29
期刊:
影响因子:
--
通讯作者:
Ding YQ
中科院分区:
文献类型:
--
作者:
Ma LL;Shen L;Tong GH;Tang N;Luo Y;Guo LL;Hu CT;Huang YX;Huang G;Jing FY;Liu C;Li ZY;Zhou N;Yan QW;Lei Y;Zhu SJ;Cheng ZQ;Cao GW;Deng YJ;Ding YQ
Directional migration is a cost-effective movement allowing invasion and metastatic spread of cancer cells. Although migration related to cytoskeletal assembly and microenvironmental chemotaxis has been elucidated, little is known about interaction between extracellular and intracellular molecules for controlling the migrational directionality. A polarized expression of prohibitin (PHB) in the front ends of CRC cells favors metastasis and is correlated with poor prognosis for 545 CRC patients. A high level of vascular endothelial growth factor (VEGF) in the interstitial tissue of CRC patients is associated with metastasis. VEGF bound to its receptor, neuropilin-1, can stimulate the activation of cell division cycle 42, which recruits intra-mitochondrial PHB to the front end of a CRC cell. This intracellular relocation of PHB results in the polymerization and reorganization of filament actin extending to the front end of the cell. As a result, the migration directionality of CRC cells is targeted towards VEGF. Together, these findings identify PHB as a key modulator of directional migration of CRC cells and a target for metastasis.
登录
查看更多内容
影响因子:
7.8
作者:
Nobes, C D;Hall, A
通讯作者:
Hall, A
影响因子:
21.3
作者:
Gloerich, Martijn;ten Klooster, Jean Paul;Bos, Johannes L.
通讯作者:
Bos, Johannes L.
影响因子:
4.8
作者:
Chen, Hairong;Bai, Jin;Zhou, Jianwei
通讯作者:
Zhou, Jianwei
影响因子:
64.5
作者:
Etienne-Manneville, S;Hall, A
通讯作者:
Hall, A
影响因子:
82.9
作者:
Kolonin, MG;Saha, PK;Arap, W
通讯作者:
Arap, W